Spontaneous cryptococcal peritonitis is an uncommon infection that predominantly encountered in immunocompromised. Its clinical presentation is indistinguishable from spontaneous bacterial peritonitis and often results in fatal outcome. Liver disease is an under recognized predisposition for cryptococcal disease. We report a case of spontaneous cryptococcal peritonitis in HIV-negative, non-diabetic female patient with chronic hepatitis C related cirrhosis. Cryptococcus infection was diagnosed by India ink and culture of ascetic fluid. The patient was successfully treated with fluconazole and she was well at the follow up of 9 months. Early clinical suspicion and initiation of antifungal are of paramount to save the patient's life.
INTRODUCTION
Spontaneous bacterial peritonitis (SBP) is a common complication in cirrhotic patients with ascites. Clinically it manifests, as fever, abdominal pain and abdominal tenderness. The diagnosis is confirmed by the presence of >250 neutrophils/mm 3 in the ascetic fluid and by demonstration of bacteria on Gram stained smear or peritoneal fluid culture [1] . Cryptococcal peritonitis is an uncommon infection and it is rarely reported. Delayed diagnosis of cryptococcal peritonitis due to its rarity and the fact that its presentation is indistinguishable from SBP often results in fatal outcome [2] . We present a case of spontaneous cryptococcal peritonitis in a patient with decompensated cirrhosis who successfully treated with fluconazole. which did not show any reduction after 2 days of cefotaxime. The development of fever and the persistence of high PMLs in the ascetic fluid after 2 days of starting antibiotic raise the possibility of SFP in our patient so we asked for India ink preparation after which the diagnosis was confirmed.
Case Report
Clinician should consider a diagnostic work up and empirical treatment for cryptococcal peritonitis if cell counts in ascetic fluid revealed an elevated leukocyte count but bacterial culture remains negative after 48 hours. Two recent reports in the literatures suggest performing cytology and India ink preparation on ascetic fluid and testing cryptococcal antigen, in the serum and ascetic fluid, may assist in the diagnostic evaluation of patients with suspected cryptococcal peritonitis [11,12,13].
There are no studies evaluating treatment of cryptococcal infection involving sites other than lungs and central nervous system (CNS). In general infection at a single site in the absence of CNS disease, fungemia or risk factors for immunosuppression may be managed with fluconazole for 6-12 months [14]. Our patient had no fungemia and was successfully treated with fluconazole for 6 months. Her ascetic fluid fungal culture was sterile 3 weeks after the index one.
The mortality rate in cirrhotic patients developing cryptococcal peritonitis is high, about 70% to 80% of the patients died [3,15]. The very poor outcome of these patients is likely to be associated with the underlying advanced liver dysfunction, systemic dissemination and delay in antifungal treatment [10] . In our patient the diagnosis of cryptococcal peritonitis was suspected early and consequently fluconazole started at appropriate time so she was saved. We concluded that Cryptococcus neoformans should be considered as a causative organism for spontaneous peritonitis in cirrhotic patients. Early clinical suspicion and timely initiation of antifungal are of paramount.
